The results showed that the prognostic performance of the proliferation module was limited to the ER+/HER2− subgroup, and genes associated with tumor invasion and immune response have prognostic value in ER−/HER2− or ER−/HER2+ subtypes. Here, ERBB2 is linked to neoplasm.